BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11309641)

  • 1. Can estrogen or selective estrogen-receptor modulators preserve cognitive function in elderly women?
    Mayeux R
    N Engl J Med; 2001 Apr; 344(16):1242-4. PubMed ID: 11309641
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive function in postmenopausal women treated with raloxifene.
    Yaffe K; Krueger K; Sarkar S; Grady D; Barrett-Connor E; Cox DA; Nickelsen T;
    N Engl J Med; 2001 Apr; 344(16):1207-13. PubMed ID: 11309635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
    Klein KP; Herrington DM
    Medscape Womens Health; 2002; 7(5):2. PubMed ID: 12466731
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of raloxifene on cognitive function in postmenopausal women: a randomized clinical trial.
    Haskell SG; Richardson ED
    Conn Med; 2004; 68(6):355-8. PubMed ID: 15266884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women.
    da Costa LS; de Oliveira MA; Rubim VS; Wajngarten M; Aldrighi JM; Rosano GM; Neto CD; Gebara OC
    Am J Cardiol; 2004 Dec; 94(11):1453-6. PubMed ID: 15566926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiestrogens--benefits of estrogens without their disadvantages?].
    Välimäki MJ; Tiitinen A
    Duodecim; 1998; 114(19):1885, 1887-8. PubMed ID: 11717742
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormones and the brain: more studies.
    Harv Womens Health Watch; 2001 Jan; 8(5):5. PubMed ID: 11137972
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter by Choi et al regarding article, "Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors".
    Choi BG; Vilahur G; Badimon JJ
    Circulation; 2009 Oct; 120(17):e147; author reply e148. PubMed ID: 19858421
    [No Abstract]   [Full Text] [Related]  

  • 9. [Additional effect of SERM: central nervous system].
    Honjo H
    Clin Calcium; 2004 Oct; 14(10):69-72. PubMed ID: 15577134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

  • 11. Raloxifene.
    Gass ML
    South Med J; 1999 Nov; 92(11):1120-3. PubMed ID: 10586846
    [No Abstract]   [Full Text] [Related]  

  • 12. Raloxifene for hormone replacement therapy (HRT).
    Adams D
    N Z Med J; 2005 May; 118(1214):U1451. PubMed ID: 15886741
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T; Mannella P; Genazzani AR
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of raloxifen on depression and cognition in ovariectomized rats.
    Karahancer M; Cirpan T; Kanit L; Terek MC; Dikmen Y; Ozsener S
    Fertil Steril; 2008 Jan; 89(1):240-2. PubMed ID: 17509592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
    Vogelvang TE; Mijatovic V; van der Mooren MJ; Pinsdorf U; von Bergmann K; Netelenbos JC; Lütjohann D
    Maturitas; 2005 Apr; 50(4):312-20. PubMed ID: 15780532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective estrogen receptor modulators (SERM's) in postmenopausal women].
    Kleiverda G
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2446-7. PubMed ID: 10608980
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
    Ohta H
    Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with raloxifene].
    Szúcs J; Pávó I; Jurida N
    Orv Hetil; 2000 Jan; 141(5):237-40. PubMed ID: 10697982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.